Celcuity [CELC] vs Bio-Techne [TECH] Detailed Stock Comparison

Celcuity Inc.

NASDAQ
Loading...

Bio-Techne Corporation

NASDAQ
Loading...

TLDR: Quick Comparison Summary

Based on 21 vital metrics comparison: Celcuity Inc. wins in 2 metrics, Bio-Techne Corporation wins in 14 metrics, with 0 ties. Bio-Techne Corporation appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Celcuity Inc. Bio-Techne Corporation Better
P/E Ratio (TTM) -29.95 117.16 Bio-Techne Corporation
Price-to-Book Ratio 58.74 4.55 Bio-Techne Corporation
Debt-to-Equity Ratio 320.13 20.07 Bio-Techne Corporation
PEG Ratio -2.12 -0.82 Bio-Techne Corporation
EV/EBITDA -33.70 28.87 Bio-Techne Corporation
Profit Margin (TTM) 0.00% 6.41% Bio-Techne Corporation
Operating Margin (TTM) 0.00% 14.51% Bio-Techne Corporation
EBITDA Margin (TTM) N/A 14.51% N/A
Return on Equity -163.80% 3.80% Bio-Techne Corporation
Return on Assets (TTM) -30.24% 6.09% Bio-Techne Corporation
Free Cash Flow (TTM) $-153.53M $256.55M Bio-Techne Corporation
Dividend Yield N/A 0.62% N/A
1-Year Return 631.21% 6.89% Celcuity Inc.
Price-to-Sales Ratio (TTM) N/A 7.35 N/A
Enterprise Value $5.80B $9.19B Bio-Techne Corporation
EV/Revenue Ratio N/A 7.56 N/A
Gross Profit Margin (TTM) N/A 62.72% N/A
Revenue per Share (TTM) $0 $8 Bio-Techne Corporation
Earnings per Share (Diluted) $-3.80 $0.49 Bio-Techne Corporation
Beta (Stock Volatility) 0.42 1.47 Celcuity Inc.
Short % of Float 27.48% 5.09% Bio-Techne Corporation

Celcuity Inc. vs Bio-Techne Corporation Stock Performance Analysis

Loading Price Chart...

CELC
TECH

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Celcuity Inc.-0.35%0.93%-35.91%-23.20%-13.64%-12.24%
Bio-Techne Corporation4.02%6.69%29.72%15.08%-4.29%-5.83%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Celcuity Inc.631.21%724.49%239.92%549.67%549.67%549.67%
Bio-Techne Corporation6.89%-31.20%-49.99%96.15%179.21%318.28%

Performance & Financial Health Analysis: Celcuity Inc. vs Bio-Techne Corporation

MetricCELCTECH
Market Information
Market Cap i$5.49B$9.07B
Market Cap CategoryMid capMid cap
10 Day Avg. Volume i745,7912,151,790
90 Day Avg. Volume i749,2272,370,067
Last Close$88.24$56.17
52 Week Range$11.27 - $151.02$43.20 - $72.16
% from 52W High-41.57%-22.16%
All-Time High$151.02 (May 04, 2026)$135.96 (Sep 20, 2021)
% from All-Time High-41.57%-58.69%
Growth Metrics
Quarterly Revenue GrowthN/A-0.01%
Quarterly Earnings GrowthN/A0.14%
Financial Health
Profit Margin (TTM) i0.00%0.06%
Operating Margin (TTM) i0.00%0.15%
Return on Equity (TTM) i-1.64%0.04%
Debt to Equity (MRQ) i320.1320.07
Cash & Liquidity
Book Value per Share (MRQ)$2.08$12.62
Cash per Share (MRQ)$9.13$0.93
Operating Cash Flow (TTM) i$-153,280,000$251.25M
Levered Free Cash Flow (TTM) i$-96,047,504$274.30M
Dividends
Last 12-Month Dividend Yield iN/A0.62%
Last 12-Month Dividend iN/A$0.40

Valuation & Enterprise Metrics Analysis: Celcuity Inc. vs Bio-Techne Corporation

MetricCELC (Apr 24, 2026)TECH (Nov 10, 2025)
Price Ratios
P/E Ratio (TTM) i-29.95117.16
Forward P/E i-111.2926.21
PEG Ratio i-2.12-0.82
Price to Sales (TTM) iN/A7.35
Price to Book (MRQ) i58.744.55
Market Capitalization
Market Capitalization i$5.49B$9.07B
Enterprise Value i$5.80B$9.19B
Enterprise Value Metrics
Enterprise to Revenue iN/A7.56
Enterprise to EBITDA i-33.7028.87
Risk & Other Metrics
Beta i0.421.47
Book Value per Share (MRQ) i$2.08$12.62

Financial Statements Comparison: Celcuity Inc. vs Bio-Techne Corporation

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricCELC (2025)TECH (2025)
Revenue/Sales i01.22B
Cost of Goods Sold iN/A429.36M
COGS % of Revenue i-35.2%
Gross Profit iN/A790.27M
Gross Margin i-64.8%
Research & Development i145.00M99.50M
Operating Income (EBIT) i-172.19M242.80M
Operating Margin i-19.9%
EBITDA i-159.73M357.57M
EBITDA Margin i-29.3%
Pre-Tax Income i-177.04M98.46M
Pre-Tax Income % of Revenue i-8.1%
Income Tax i025.06M
Income Tax % of Revenue i-2.1%
Net Income (Profit) i-177.04M73.40M
Profit Margin i-6.0%

Balance Sheet & Liquidity Metrics

MetricCELC (2025)TECH (2025)
Cash & Equivalents i165.70M162.19M
Total Current Assets i465.66M608.30M
Total Current Assets % of Revenue i-49.9%
Total Current Liabilities i44.15M175.85M
Total Current Liabilities % of Revenue i-14.4%
Long-Term Debt i321.85M429.96M
Long-Term Debt % of Revenue i-35.3%
Total Shareholders Equity i100.56M1.92B
Retained Earnings i-448.90M1.07B
Retained Earnings % of Revenue i-87.4%
Property, Plant & Equipment i51,00073.40M

Cash Flow Statement Comparison

MetricCELC (2025)TECH (2025)
Operating Cash Flow i-156.66M185.64M
Operating Cash Flow % of Revenue i-15.2%
Capital Expenditures i-249,000-31.01M
Free Cash Flow i-153.53M256.55M
FCF Margin i-21.0%
Debt Repayment iN/A-77.00M
Common Stock Repurchase iN/A-275.73M

Short Interest & Institutional Ownership Analysis

MetricCELCTECH
Shares Short i8.80M6.94M
Short Ratio i12.802.59
Short % of Float i27.48%5.09%
Shares Outstanding i48.24M154.97M
Float Shares i29.66M153.94M
% Held by Insiders i10.21%0.28%
% Held by Institutions i98.25%102.89%
% Held by Public i-8.46%-3.17%

Dividend Analysis & Yield Comparison: Celcuity Inc. vs Bio-Techne Corporation

MetricCELCTECH
Last 12-Month Dividend iN/A$0.40
Last 12-Month Dividend Yield iN/A0.62%
3-Year Avg Annual Dividend iN/A$0.32
3-Year Avg Dividend Yield iN/A0.12%
3-Year Total Dividends iN/A$0.96
Ex-Dividend DateN/AFeb 13, 2026